Holen Sie sich die Stockscreener-App
192.15
2.62%
-5.17
Handel nachbörslich:
192.06
-0.09
-0.05%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt HUM?
Forum
Prognose
Dividendenhistorie
Schlusskurs vom Vortag:
$197.32
Offen:
$198.71
24-Stunden-Volumen:
1.30M
Relative Volume:
0.63
Marktkapitalisierung:
$23.07B
Einnahmen:
$129.66B
Nettoeinkommen (Verlust:
$1.20B
KGV:
19.59
EPS:
9.8083
Netto-Cashflow:
$375.00M
1W Leistung:
+8.05%
1M Leistung:
+10.67%
6M Leistung:
-31.43%
1J Leistung:
-33.80%
1-Tages-Spanne:
$191.89
$199.79
1-Wochen-Bereich:
$177.54
$203.50
52-Wochen-Spanne:
$163.11
$315.35
Humana Inc Stock (HUM) Company Profile
Firmenname
Humana Inc
Sektor
Branche
Telefon
(502) 580-1000
Adresse
101 E. MAIN STREET, LOUISVILLE, KY
Compare HUM vs UNH, CVS, CI, ELV
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
HUM
Humana Inc
|
192.15 | 23.07B | 129.66B | 1.20B | 375.00M | 9.8083 |
UNH
Unitedhealth Group Inc
|
304.33 | 276.23B | 447.57B | 12.81B | 16.08B | 13.19 |
CVS
Cvs Health Corp
|
79.33 | 101.67B | 402.11B | 1.73B | 7.81B | 1.3835 |
CI
Cigna Group
|
271.25 | 71.52B | 274.88B | 6.29B | 8.39B | 22.19 |
ELV
Elevance Health Inc
|
311.53 | 68.43B | 199.13B | 5.66B | 3.17B | 25.11 |
Humana Inc Stock (HUM) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-02-12 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2026-02-02 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2026-01-07 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2025-12-05 | Hochstufung | Jefferies | Hold → Buy |
| 2025-10-14 | Eingeleitet | Goldman | Sell |
| 2025-09-22 | Eingeleitet | Evercore ISI | In-line |
| 2025-05-01 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2024-11-06 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2024-10-11 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2024-10-08 | Hochstufung | Bernstein | Mkt Perform → Outperform |
| 2024-10-07 | Herabstufung | Jefferies | Buy → Hold |
| 2024-10-07 | Herabstufung | TD Cowen | Buy → Hold |
| 2024-10-03 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2024-10-02 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2024-10-02 | Herabstufung | Leerink Partners | Outperform → Market Perform |
| 2024-10-02 | Herabstufung | Stephens | Overweight → Equal-Weight |
| 2024-06-26 | Eingeleitet | Piper Sandler | Overweight |
| 2024-06-24 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2024-04-02 | Herabstufung | BofA Securities | Buy → Neutral |
| 2024-03-22 | Eingeleitet | Raymond James | Mkt Perform |
| 2024-03-13 | Herabstufung | Argus | Buy → Hold |
| 2024-03-06 | Eingeleitet | Barclays | Equal Weight |
| 2024-01-26 | Herabstufung | Cantor Fitzgerald | Overweight → Neutral |
| 2024-01-25 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2023-12-12 | Hochstufung | Argus | Hold → Buy |
| 2023-11-08 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2023-07-07 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2023-06-23 | Herabstufung | Argus | Buy → Hold |
| 2023-04-21 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2022-12-13 | Hochstufung | Goldman | Neutral → Buy |
| 2022-10-26 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2022-09-20 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2022-06-17 | Eingeleitet | Loop Capital | Buy |
| 2022-05-27 | Eingeleitet | Bernstein | Mkt Perform |
| 2022-04-13 | Hochstufung | UBS | Neutral → Buy |
| 2022-01-06 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2021-12-16 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2021-12-14 | Eingeleitet | Goldman | Neutral |
| 2021-11-04 | Bestätigt | Barclays | Overweight |
| 2021-11-04 | Bestätigt | Credit Suisse | Outperform |
| 2021-11-04 | Bestätigt | Morgan Stanley | Overweight |
| 2021-11-04 | Bestätigt | Oppenheimer | Outperform |
| 2021-11-04 | Bestätigt | RBC Capital Mkts | Outperform |
| 2021-09-27 | Eingeleitet | SVB Leerink | Outperform |
| 2021-09-10 | Eingeleitet | Cowen | Outperform |
| 2021-09-09 | Fortgesetzt | Barclays | Overweight |
| 2021-07-09 | Eingeleitet | Seaport Global Securities | Neutral |
| 2021-05-19 | Eingeleitet | Wells Fargo | Equal Weight |
| 2021-01-04 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2020-10-02 | Eingeleitet | Bernstein | Mkt Perform |
| 2020-07-01 | Eingeleitet | SVB Leerink | Outperform |
| 2020-06-16 | Herabstufung | Cowen | Outperform → Market Perform |
| 2020-06-05 | Eingeleitet | Goldman | Buy |
| 2020-01-03 | Bestätigt | JP Morgan | Overweight |
| 2019-10-18 | Eingeleitet | Mizuho | Buy |
| 2019-09-30 | Herabstufung | BMO Capital Markets | Outperform → Market Perform |
| 2019-09-12 | Eingeleitet | Deutsche Bank | Hold |
| 2019-08-12 | Hochstufung | Cantor Fitzgerald | Neutral → Overweight |
| 2019-04-23 | Eingeleitet | UBS | Neutral |
| 2019-01-14 | Eingeleitet | Stephens | Overweight |
| 2018-12-20 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2018-11-08 | Bestätigt | BofA/Merrill | Buy |
| 2018-09-13 | Eingeleitet | Barclays | Overweight |
| 2018-07-12 | Fortgesetzt | Morgan Stanley | Overweight |
| 2018-07-06 | Bestätigt | Piper Jaffray | Overweight |
| 2018-06-01 | Fortgesetzt | Citigroup | Buy |
| 2018-02-08 | Hochstufung | Credit Suisse | Neutral → Outperform |
| 2018-02-08 | Bestätigt | Leerink Partners | Outperform |
| 2018-01-12 | Hochstufung | Jefferies | Hold → Buy |
Alle ansehen
Humana Inc Aktie (HUM) Neueste Nachrichten
Humana and Thor hit the Casualty List, can revive and thrive Humana and Thor Hit the Casualty List - InsuranceNewsNet
Humana Adds Healthcare Investment Expert To Board As Valuation Draws Focus - Yahoo Finance
Pharma News: Is Humana Inc stock trending bullishPortfolio Risk Summary & Free Safe Capital Growth Stock Tips - baoquankhu1.vn
Humana adds healthcare investor Robert Field to board By Investing.com - Investing.com Australia
Humana Inc. $HUM Shares Purchased by Massachusetts Financial Services Co. MA - MarketBeat
Humana Inc. (HUM) Expands Board of Directors with New Appointmen - GuruFocus
Humana's Board Adds Investor Expert as Growth and Margin Battle Heats Up in 2026 - Bitget
Humana Elects Healthcare Investment Expert Robert S. Field to Board of Directors in 2026 - Minichart
Meta introduces prescription AI glasses, Gyde acquires Avid Health, b.well Connected Health partners with Noom, Welldoc, and Humana - VatorNews
Humana (HUM) Elects Robert Field to Board of Directors - GuruFocus
Humana Expands Board, Elects Robert Field as Director - TipRanks
Humana Inc. stock underperforms Friday when compared to competitors - MarketWatch
Humana (NYSE: HUM) adds healthcare investor Robert Field to its board - Stock Titan
Humana Elects Robert S. Field to Board of Directors - InsuranceNewsNet
Humana hires chief technology officer - The Business Journals
3 Health Insurance Stocks to Play On the Medicare Hike - Benzinga
Can UnitedHealth Ease Margin Pressure on CMS Tailwinds? - TradingView — Track All Markets
UnitedHealth Rockets 11%, Humana Climbs 9% as Medicare Advantage Rate Decision Crushes Regulatory Fears - AOL.com
Humana Is Still A Hold Despite The Medicare Advantage Rate Boost (NYSE:HUM) - Seeking Alpha
bwell Connected Health Platform Integrated by Humana for Member Data Access - TipRanks
Medicare Advantage "Relief Rally": Humana and UnitedHealth Surge as CMS Finalizes 2.48% Rate Increase for 2027 - FinancialContent
b.well announces partnerships with Noom, Humana, Welldoc - MobiHealthNews
Humana and UnitedHealth Surge as Medicare Advantage Payments Ris - GuruFocus
4 Health Care Stocks Whale Activity In Today's Session - Benzinga
Humana Bets on Pharmacists to Lift Chronic Care Outcomes - Zacks Investment Research
Humana, Noom and Welldoc team up with b.well to expand health data access as part of CMS push - Fierce Healthcare
Humana Partners with b.well for Health Data Interoperability - National Today
Humana (HUM) Enhances Health Data Access with b.well Partnership - GuruFocus
Humana (HUM) Valuation Check After Medicare Advantage Payment Rate Boost And Share Price Rebound - simplywall.st
Humana Goes Live with b.well to Deliver on Health Data Interoperability Commitments - The Joplin Globe
Buy UnitedHealth or Humana Stock as Medicare Advantage Rates Increase? - qz.com
Humana Launches Pharmacist Quality Rewards Program in Ohio - National Today
LAWSUIT UPDATE: Investors in Shares of Humana Inc. (NYSE: HUM) Should Contact The Shareholders Foundation - newswire.com
Humana (HUM) Receives Raised Price Target from Evercore ISI Grou - GuruFocus
Humana (HUM) Launches Pharmacist Quality Rewards in Ohio - GuruFocus
Humana (NYSE:HUM) Stock Price Expected to Rise, Evercore Analyst Says - MarketBeat
Humana Surges Above 50-Day MA. Should You Buy HUM Stock on CMS Rate Changes Here? - Yahoo Finance
What You Need To Know Ahead of Humana's Earnings Release - Barchart.com
USA Launch Value-Based Pharmacist Quality Rewards Program to Improve Chronic Condition Care - Business Wire
Humana price target raised to $210 from $196 at BofA - Yahoo Finance
Mizuho cuts Humana stock price target on Medicare Advantage risks - Investing.com
Sivik Global Healthcare LLC Cuts Stock Holdings in Humana Inc. $HUM - MarketBeat
Humana (HUM) Moves 7.9% Higher: Will This Strength Last? - Yahoo Finance
Humana (HUM) Is Up 13.7% After 2027 Medicare Advantage Rate Hike and New Impact Report - simplywall.st
UnitedHealth (UNH) vs. Humana (HUM): Which Healthcare Stock Is the Better Bet After the CMS Update? - TipRanks
Humana (HUM) Climbs 7.9% Ahead of Earnings - Insider Monkey
John Dorfman: Humana, Thor hit Casualty List - TribLIVE.com
Humana and UnitedHealth Shares Skyrocket, What You Need To Know - Yahoo Finance
Humana Stock Surges on Favorable Medicare Payment Changes - timothysykes.com
New Medicare Payment Rate Released. Why UnitedHealth, Humana Are Popping. - Barron's
Humana rebounds on stronger Medicare rates - The Business Journals
Finanzdaten der Humana Inc-Aktie (HUM)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.67%
0.57%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):